Prescription of first-line therapy (ART-AQ) | Antibiotic use | |||
---|---|---|---|---|
Adjusted odds ratio [95% CI] | p-value | Adjusted odds ratio [95% CI] | p-value | |
Age group | ||||
<5 | 1.0 | 1.0 | ||
5–12 | 3.6 [2.6–4.9] | <0.001 | - | - |
13–59 | 2.5 [2.0–3.1] | <0.001 | 0.53 [0.44–0.64] | <0.001 |
≥60 | 2.6 [1.8–3.9] | <0.001 | 0.55 [0.37–0.83] | 0.004 |
Facility type | ||||
Non-government | 1.0 | - | - | |
Government | 6.3 [3.6–11.1] | <0.001 | - | - |
Mode of diagnosis | ||||
Presumptive | 1.0 | 1.0 | ||
Laboratory confirmed | 9.7 [5.2–18.2] | <0.001 | 0.68 [0.41–1.1] | 0.13 |
Anti-malarial treatment prescribed | ||||
Combination therapy (ART-AQ) | - | - | 1.0 | |
Combination therapy (Other ACT) | - | - | - | - |
Monotherapy (Artemisinin based) | - | - | 1.2 [0.97–1.4] | 0.11 |
Monotherapy (Non-artemisinin) | - | - | 1.4 [1.1–1.9] | 0.02 |